These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 575067)

  • 1. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
    Karakousis CP; Holtermann OA; Holyoke ED
    Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
    Rossof AH; Coltman CA; Jones SE; Talley RW
    Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
    Thigpen JT; Samson MK
    Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH; Montella D; Rosenbaum C; Schwen M
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
    Zidar BL; Benjamin RS; Frank J; Lane M; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):71-4. PubMed ID: 6837508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy using cisplatin in bone and soft tissue sarcoma].
    Isu K; Goto M; Yamawaki S; Ubayama Y
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):100-4. PubMed ID: 3467652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.
    Maki RG; Kraft AS; Scheu K; Yamada J; Wadler S; Antonescu CR; Wright JJ; Schwartz GK
    Cancer; 2005 Apr; 103(7):1431-8. PubMed ID: 15739208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study.
    Vaughn CB; McKelvey E; Balcerzak SP; Loh K; Stephens R; Baker L
    Cancer Treat Rep; 1984 Feb; 68(2):409-10. PubMed ID: 6607770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study.
    Thigpen JT; Vaughn C; Stuckey WJ
    Cancer Treat Rep; 1981; 65(9-10):881-2. PubMed ID: 7273022
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
    Chary KK; Higby DJ; Henderson ES; Swinerton KD
    Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1857-61. PubMed ID: 3707148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.